Guy I. Sydney, MD
Clinical Fellow T32Cards
About
Research
Publications
2026
Immune therapies in type 1 diabetes deserve immune biomarkers.
Sydney GI, Paschou SA. Immune therapies in type 1 diabetes deserve immune biomarkers. Diabetes Res Clin Pract 2026, 113435. PMID: 42442554, DOI: 10.1016/j.diabres.2026.113435.Peer-Reviewed Original Research
2025
Towards insulin independence in type 1 diabetes: Prospects for prevention and cure
Sydney G, Perdigoto A, Herold K. Towards insulin independence in type 1 diabetes: Prospects for prevention and cure. PLOS Medicine 2025, 22: e1004813. PMID: 41289263, PMCID: PMC12646415, DOI: 10.1371/journal.pmed.1004813.Peer-Reviewed Original ResearchMON-624 Insulin Therapy in Steroid-Induced Ketoacidosis (SIKA) with Normoglycemia
Sydney G. MON-624 Insulin Therapy in Steroid-Induced Ketoacidosis (SIKA) with Normoglycemia. Journal Of The Endocrine Society 2025, 9: bvaf149.985. PMCID: PMC12543755, DOI: 10.1210/jendso/bvaf149.985.Peer-Reviewed Original ResearchSUN-770 Severe Hypocalcemia in Diffuse Metastatic Prostate Cancer: Impact of Osteoblastic Lesions and Denosumab Therapy
Sydney G, Balasubramanian P. SUN-770 Severe Hypocalcemia in Diffuse Metastatic Prostate Cancer: Impact of Osteoblastic Lesions and Denosumab Therapy. Journal Of The Endocrine Society 2025, 9: bvaf149.718. PMCID: PMC12545657, DOI: 10.1210/jendso/bvaf149.718.Peer-Reviewed Original ResearchMON-117 GnRH Agonist Therapy Induced Pituitary Apoplexy
Sydney G, balasubramanian P. MON-117 GnRH Agonist Therapy Induced Pituitary Apoplexy. Journal Of The Endocrine Society 2025, 9: bvaf149.1445. PMCID: PMC12544274, DOI: 10.1210/jendso/bvaf149.1445.Peer-Reviewed Original ResearchSAT-615 Acute Liver Injury Impairing Ketogenesis and Insulin Clearance in a Type 1 Diabetic with Recurrent Hypoglycemia
Sydney G. SAT-615 Acute Liver Injury Impairing Ketogenesis and Insulin Clearance in a Type 1 Diabetic with Recurrent Hypoglycemia. Journal Of The Endocrine Society 2025, 9: bvaf149.1141. PMCID: PMC12544677, DOI: 10.1210/jendso/bvaf149.1141.Peer-Reviewed Original ResearchMoving the Goalposts Closer: Using Intermediate End Points in Type 1 Diabetes Prevention Trials.
Sydney G, Wu S, Herold K. Moving the Goalposts Closer: Using Intermediate End Points in Type 1 Diabetes Prevention Trials. Diabetes Care 2025, 48: 1318-1319. PMID: 40690655, PMCID: PMC12279035, DOI: 10.2337/dci25-0041.Commentaries, Editorials and LettersCystic Fibrosis and Hemochromatosis Carriers May Be Prone to Glucagon-like Peptide-1 Agonist Pancreatitis: 3 Cases
Sydney G, Do T, West W, Uwaifo G. Cystic Fibrosis and Hemochromatosis Carriers May Be Prone to Glucagon-like Peptide-1 Agonist Pancreatitis: 3 Cases. JCEM Case Reports 2025, 3: luaf104. PMID: 40384889, PMCID: PMC12078934, DOI: 10.1210/jcemcr/luaf104.Peer-Reviewed Original ResearchBeyond Glucose Levels: Redefining Diabetic Ketoacidosis—A Case of Hypoglycemic Diabetic Ketoacidosis
Sydney G. Beyond Glucose Levels: Redefining Diabetic Ketoacidosis—A Case of Hypoglycemic Diabetic Ketoacidosis. AACE Endocrinology And Diabetes 2025, 11: 148-150. PMID: 40201456, PMCID: PMC11973659, DOI: 10.1016/j.aace.2025.01.001.Peer-Reviewed Original Research
2024
Impact of a tracheal aspirate culture diagnostic test stewardship intervention in a tertiary care PICU
Chiotos K, Lee G, Sydney G, Woods-Hill C, Wolfe H, Stinson H, Piccione J, Blumenthal J, Keim G, Li Y, Traynor D, Dudhia A, Doll A, Harris R, Gerber J. Impact of a tracheal aspirate culture diagnostic test stewardship intervention in a tertiary care PICU. Infection Control And Hospital Epidemiology 2024, 45: 943-951. PMID: 39229740, DOI: 10.1017/ice.2024.105.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
Get In Touch
Contacts
Email